Biological E to amp up jab production with Rs 1,800-crore investment

As India is cementing Hyderabad position as the Vaccine Capital of the World, Biological E has announced its expansion plans for vaccine manufacturing with

Related Keywords

Hyderabad ,Andhra Pradesh ,India ,K Chandrashekar Rao ,Shakthim Nagappan ,Jayesh Ranjan ,Janssen Covid ,Telangana Lifesciences ,Rama Rao ,Mahima Datla ,States Pharmacopeia ,Glaxosmithkline ,Us International Development Finance Corporation ,Industries Principal ,Life Sciences ,Be Limited ,Dupont ,Novartis ,Biologicale Managing Director Mahima ,Principal Secretary Jayesh Ranjan ,Vaccine Capital ,Chief Ministerk Chandrashekar Rao ,Typhoid Vaccine ,Covid Vaccine ,Tetanus Toxide Ampoules ,Pertussis Vaccine ,Generic Injectables ,Genome Valley ,Mclean Manufacturing ,Ferring Pharma ,United States Pharmacopeia ,Branded Formulations ,Speciality Generic Injectables ,Synthetic Biology ,Development Finance Corporation ,Drugs Controller General ,India News ,Covid ,Xpand ,Company ,Minister ,Biological ,Speciality ,00 Crore ,Rore ,